Does Mutational Analysis Influence the Management of Differentiated Thyroid Cancers?

It is evident that BRAF does predict recurrence and unfavorable characteristics in differentiated thyroid cancers (DTC).

Source: ENTtoday - TRIO Best Practices - June 11, 2018 Category: ENT & OMF Authors: Ameya Asarkar, MD, Manish Shaha, MD, Ashok Shaha, MD, and Cherie‐Ann O. Nathan, MD Tags: TRIO Best Practices diagnosis differentiated thyroid cancers DTC treatment Source Type: research